Litigation Details for PAR PHARMACEUTICAL, INC. v. LUITPOLD PHARMACEUTICALS, INC. (D.N.J. 2016)
✉ Email this page to a colleague
PAR PHARMACEUTICAL, INC. v. LUITPOLD PHARMACEUTICALS, INC. (D.N.J. 2016)
| Docket | ⤷ Sign Up | Date Filed | 2016-04-22 |
| Court | District Court, D. New Jersey | Date Terminated | 2017-10-31 |
| Cause | 35:271 Patent Infringement | Assigned To | William H. Walls |
| Jury Demand | None | Referred To | Cathy L. Waldor |
| Patents | 9,119,876; 9,295,657 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in PAR PHARMACEUTICAL, INC. v. LUITPOLD PHARMACEUTICALS, INC.
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for PAR PHARMACEUTICAL, INC. v. LUITPOLD PHARMACEUTICALS, INC. (D.N.J. 2016)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2017-02-01 | 109 | are two patents at issue in this case. The first patent, United States Patent No. 9,119,876 (the “‘…atse id, Ex. A. The second patent, Patent No. 9,295,657 (the “‘657 patent”), which is a continuation …infringement of their patents. Id. ¶1J 65—80. I. The Patents-in-S alt …infringes the Patents-in-Suit.” Id. The Complaint contains four counts of patent infringement…s ‘876 patent under 35 U.S.C. § 271(e)(2) and that Defendant will infringe the ‘876 patent under | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
